Serological Evidence Of Brucella Infection In Acute Febrile Illness Patients At A Tertiary Care Centre: A Prospective Study
International Journal of Drug Delivery Technology · 11.05.2026 · 16 (26s)
DOI: 10.25258/ijddt.16.26s.98 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.05.2026. Verfasst von Dr. Vikash Yadav und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Brucellosis is a zoonotic disease, a global health concern that remains underdiagnosed in humans due to its non-specific clinical presentations. India, is particularly vulnerable to brucellosis due to its high-density livestock farming. This study aimed to estimate the seroprevalence of brucellosis in individuals presenting with non-specific clinical symptoms. Materials and Methods: This prospective follow up study was conducted in departments of microbiology, lhmc and associated hospitals and department of medicine in lhmc from april 2024 to august 2025. A total of 132 serum samples were collected from individuals suffering from acute febrile illness for brucellosis testing. Detection of anti-brucella igm antibodies in serum samples was performed by commercially available elisa kit according to the manufacturer's instruction.
Results
Out of 132 subjects, 18 cases were caused by brucella spp (13.6%) detected by igm elisa. In brucella positive patients most commonly presenting feature along with fever were myalgia (66.75%), headache (61.1%), malaise (61.1%). While most common presenting sign were joint tenderness (27.7%), skin rash (22.2%), and jaundice (16.7%). Laboratory parameter shows raised crp (100%), leukocytosis (72.2%), and raised haematocrit (77.8%). Majority of brucella positive patients (50%) were in age group 18-25 years, median hospitalization was 10 days. Out of 18 brucella positive 4 were on monodrug therapy and 14 were on multidrug therapy. All patients discharged after full recovery no mortality seen.
Conclusion
This study demonstrates a significant seroprevalence of brucellosis among both symptomatic and asymptomatic individuals. Owing to its non-specific clinical presentation, routine serological screening is essential, particularly in high-risk populations. Furthermore, adopting a one health approach that integrates human and animal health surveillance is vital for effective prevention and control of the disease.
Zitieren
APA
Yadav, D. V., Thakur, D. P., Jais, D. M. B., & Ghotekar, D. L. (2026). Serological Evidence Of Brucella Infection In Acute Febrile Illness Patients At A Tertiary Care Centre: A Prospective Study. International Journal of Drug Delivery Technology, 16(26s). https://doi.org/10.25258/ijddt.16.26s.98
Vancouver
Yadav DV, Thakur DP, Jais DMB, Ghotekar DL. Serological Evidence Of Brucella Infection In Acute Febrile Illness Patients At A Tertiary Care Centre: A Prospective Study. International Journal of Drug Delivery Technology. 2026;16(26s). doi:10.25258/ijddt.16.26s.98
BibTeX
@article{Yadav2026,
author = {Yadav, Dr. Vikash and Thakur, Dr. Preeti and Jais, Dr. Manoj B. and Ghotekar, Dr. L.H.},
title = {Serological Evidence Of Brucella Infection In Acute Febrile Illness Patients At A Tertiary Care Centre: A Prospective Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {26s},
doi = {10.25258/ijddt.16.26s.98}
}
EUVIMED